The US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moutinho, S. Researchers and regulators plan for a future without lab animals. Nat Med 29, 2151–2154 (2023). https://doi.org/10.1038/s41591-023-02362-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02362-z
- Springer Nature America, Inc.
This article is cited by
-
Femtechs take on women’s health
Nature Biotechnology (2024)
-
Reverse translation: the key to increasing the clinical success of immunotherapy?
Genes & Immunity (2023)
-
Computational Modelling Enabling In Silico Trials for Cardiac Physiologic Pacing
Journal of Cardiovascular Translational Research (2023)